000			01775 a2200481 4500
005			20250513030602.0
264		0	_c19940127
008			199401s 0 0 eng d
022			_a0022-3565
040			_aNLM _beng _cNLM
100	1		_aZembowicz, A
245	0	0	_aInhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cDec 1993
300			_a1112-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmino Acid Oxidoreductases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAorta, Thoracic _xdrug effects
650	0	4	_aAzoles _xantagonists & inhibitors
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCattle
650	0	4	_aDrug Interactions
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aEnzyme Activation
650	0	4	_aFemale
650	0	4	_aGlutathione Peroxidase _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aIsoindoles
650	0	4	_aMale
650	0	4	_aMuscle Relaxation _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aNitric Oxide Synthase
650	0	4	_aOrganoselenium Compounds _xantagonists & inhibitors
650	0	4	_aRabbits
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSulfhydryl Compounds _xpharmacology
650	0	4	_aSwine
700	1		_aHatchett, R J
700	1		_aRadziszewski, W
700	1		_aGryglewski, R J
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 267 _gno. 3 _gp. 1112-8
999			_c7504793 _d7504793